Penile Implants Market Report 2026

The penile implants market size has grown strongly in recent years. It will grow from $2.11 billion in 2025 to $2.32 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to limited awareness of penile implants, reliance on oral medication and injections, social stigma surrounding erectile dysfunction, inadequate surgical expertise, fragmented patient follow-up systems.

The penile implants market size is expected to see strong growth in the next few years. It will grow to $3.33 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to rising adoption of inflatable and semi-rigid implants, increasing demand for outpatient and minimally invasive procedures, growth in urology clinics and specialized centers, advancements in biocompatible materials and implant design, increasing patient awareness and preference for long-term ED solutions. Major trends in the forecast period include increasing use of ai for preoperative assessment and predictive outcomes, adoption of genomics-based personalized erectile dysfunction therapies, integration of cloud and big data for patient monitoring, use of iot-enabled devices for postoperative care and monitoring, implementation of smart manufacturing in penile implant production.

The increasing prevalence of erectile dysfunction (ED) is expected to drive the growth of the penile implants market in the coming years. Erectile dysfunction is defined as the ongoing inability to achieve or maintain an erection adequate for satisfactory sexual performance. The rising occurrence of ED is influenced by factors such as an aging population, a higher incidence of lifestyle-related conditions including diabetes, obesity, and cardiovascular diseases, psychological factors such as stress and anxiety, and improved awareness and diagnosis resulting from advancements in healthcare. Penile implants play an important role in addressing this growing prevalence by offering a durable and effective solution for patients who do not respond to drug-based therapies, thereby improving quality of life and providing a long-term treatment option for severe cases. For instance, in October 2024, according to Springer Nature, a Germany-based media company, an umbrella review reported that the pooled global prevalence of erectile dysfunction among men with diabetes is 65.8%. Therefore, the rising prevalence of erectile dysfunction is contributing to the growth of the penile implants market.

The growing awareness and acceptance of sexual health are also expected to propel the growth of the penile implants market going forward. Sexual health represents a comprehensive state of physical, emotional, mental, and social well-being related to sexuality, with an emphasis on safety, respect, and informed decision-making. Increased awareness and acceptance of sexual health help empower individuals, reduce stigma, improve health outcomes, and encourage informed choices regarding sexual well-being and relationships. Penile implants contribute to this shift by offering effective and lasting solutions for erectile dysfunction, promoting open discussions, reducing stigma, and underscoring the importance of seeking medical care for sexual health concerns. For instance, in July 2024, according to the UK Health Security Agency, a UK-based government agency, the total number of consultations provided by sexual health services in England increased by 5% in 2023 compared to 2022, with face-to-face consultations rising by 7.9% and online consultations increasing by 7.5%. Therefore, the increasing awareness and acceptance of sexual health are driving the growth of the penile implants market.

Major companies operating in the penile implants market are focusing on product innovation, particularly in the development of advanced penile prosthesis pumps, to improve both patient and physician experiences by enhancing device reliability, simplifying operation, and streamlining post-operative training for inflatable penile prostheses. A penile prosthesis pump is an implanted device located in the scrotum that enables users to achieve an erection by manually transferring fluid from a reservoir into inflatable cylinders within the penis. For example, in November 2023, Boston Scientific, a US-based medical technology company, received FDA approval for its Tenacio pump, a component of the AMS 700 inflatable penile prosthesis. The Tenacio pump features automated functionality that allows single-press deflation, addressing reliability issues such as stiction syndrome and improving ease of use. This innovation simplifies patient training and may reduce the time required by physicians during post-operative instruction.

Major companies operating in the penile implants market are Boston Scientific Corporation, Coloplast Corp, Promedon S.A., Zephyr Surgical Implants, Rigicon Inc, Penuma, Shah Prosthesis, Rocamed, Genesis MedTech Group, Guangzhou Jiedi Medical Co Ltd, Uromedica Inc, Taheri Medical Instruments, InnoMedicus AG, Tic Medizintechnik GmbH & Co KG, ZSR Biomedical Technology Co Ltd, G Surgiwear Ltd, Titan Medical Inc, UroHealth Systems Pvt Ltd, Sanghui Medical Co Ltd, Prometheus Group, Neomedic, Osbon, UroMed, Timm Medical Technologies Inc, Nuntius, Men’s Health Solutions, Allen Medical Systems.

North America was the largest region in the penile implants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the penile implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the penile implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the penile implants market by raising the cost of imported implants, medical devices, and surgical instruments, affecting hospitals and urology centers in regions such as North America and Europe. While tariffs have temporarily increased procurement costs, they have also incentivized local manufacturing, encouraged innovation in cost-effective implant designs, and strengthened supply chain resilience for ED treatment solutions.

The penile implants market research report is one of a series of new reports that provides penile implants market statistics, including penile implants industry global market size, regional shares, competitors with a penile implants market share, detailed penile implants market segments, market trends and opportunities, and any further data you may need to thrive in the penile implants industry. This penile implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Penile implants are surgically implanted medical devices used to treat erectile dysfunction (ED) in patients for whom other treatment options, such as medications or therapy, have not been effective. These devices are available in inflatable and malleable forms and provide a long-term solution by allowing men to achieve and sustain an erection, thereby enhancing sexual performance and overall quality of life.

The primary types of penile implants include inflatable penile implants, malleable penile implants, and semi-rigid penile implants. Inflatable penile implants are devices placed inside the penis that help men with erectile dysfunction attain and maintain an erection by using a pump mechanism to move fluid into cylinders implanted in the penis. Penile implants are intended for patients experiencing vascular, psychogenic, or neurological impotence. These devices are commonly manufactured using materials such as silicone, bioflex, and others. Implantation procedures may be performed in outpatient or inpatient settings, and the end users include hospitals, ambulatory surgery centers, urology centers, and others.

The penile implants market consists of sales of hydrogel implants, titanium implants, smart implants, and customizable implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.